Design, Syntheses and In Vitro Gene Delivery Efficacies of Novel Mono-, Di- and Trilysinated Cationic Lipids: A Structure−Activity Investigation
- 19 February 2004
- journal article
- research article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 47 (8) , 2123-2132
- https://doi.org/10.1021/jm030541+
Abstract
Structure−activity investigation including design, syntheses, and evaluation of relative in vitro gene delivery efficacies of a novel series of cationic amphiphiles (1 − 10) containing mono-, di-, and trilysine headgroups are described in CHO, COS-1, and HepG2 cells. Several interesting and rather unexpected transfection profiles were observed. In general, lipid 1 with the myristyl tail used in combination with DOPE as colipid exhibited superior transfection properties compared to (a) the monolysinated analogues with longer hydrocarbon tails (lipids 2 − 4), (b) the dilysine (lipids 5 − 7) and the trilysine headgroup analogues (lipids 8 − 10), and (c) commercially available LipofectAmine with multiple positive charges in its polar region. As a preliminary estimate of the relative DNA-compacting efficacies of these new lysinated cationic lipids, the hydrodynamic diameters of representative lipoplexes were measured using dynamic laser light scattering technique. Our lipoplex size data are consistent with the notion that covalent grafting of an increasing number of positively charged functional groups in the headgroup region of cationic lipids need not necessarily result in more compacted lipoplexes. Both gel retardation and DNase I sensitivity assays indicated similar lipid/DNA binding interactions for all the novel mono-, di-, and trilysinated cationic lipids. MTT-assay-based cell viability results clearly demonstrate that the overall lower transfection properties of trilysine analogues (8 − 10) compared to their mono- (1-4) and dilysinated (5−7) counterparts are unlikely to originate from differential toxicity related effects. Taken together, the present findings support the notion that caution needs to be exercised in ensuring enhanced gene delivery efficacies of cationic lipids through covalent grafting of multiple lysine functionalities in the headgroup region.Keywords
This publication has 23 references indexed in Scilit:
- Single histidine residue in head-group region is sufficient to impart remarkable gene transfection properties to cationic lipids: evidence for histidine-mediated membrane fusion at acidic pHGene Therapy, 2003
- Sterically stabilized BGTC-based lipoplexes: structural features and gene transfection into the mouse airwaysin vivoThe Journal of Gene Medicine, 2001
- Cation Substitution in Cationic Phosphonolipids: A New Concept To Improve Transfection Activity and Decrease Cellular ToxicityJournal of Medicinal Chemistry, 2000
- Novel Series of Non-Glycerol-Based Cationic Transfection Lipids for Use in Liposomal Gene DeliveryJournal of Medicinal Chemistry, 1999
- Biological barriers to cellular delivery of lipid-based DNA carriersAdvanced Drug Delivery Reviews, 1999
- A novel cationic lipid greatly enhances plasmid DNA delivery and expression in mouse lung.Proceedings of the National Academy of Sciences, 1996
- A Novel Series of Amphiphilic Imidazolinium Compounds for in Vitro and in Vivo Gene DeliveryBiochemistry, 1995
- A New Cationic Liposome Encapsulating Genetic Material. A Potential Delivery System for PolynucleotidesEuropean Journal of Biochemistry, 1995
- Liposome-mediated CFTR gene transfer to the nasal epithelium of patients with cystic fibrosisNature Medicine, 1995
- Rapid Communication: In vivo Transfection of Murine Lungs with a Functioning Prokaryotic Gene using a Liposome VehicleThe Lancet Healthy Longevity, 1989